Stay up to date on the on the latest data on novel immunotherapies used for the treatment of melanoma through this highly informative article crafted by Anna C. Pavlick DO, MBA.
This activity is intended for oncologists, dermatologists, nurses, nurse practitioners and pharmacists.
The goal of this activity is that learners will be better able to provide updats on the clinical data on novel immunomodulators in the treatment of melanoma.
Learning Objectives:
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Current treatment of patients with melanoma
- Mechanism of novel immunomodulators being evaluated for the treatment of melanoma
- Clinical trials evaluating novel immunotherapy approaches for the treatment of melanoma
- Demonstrate greater confidence
- In the ability of the interprofessional team to incorporate triplet or immunotherapy regimens
Approximate Time to Complete: 15 minutes
Credit Available: March 16, 2022 - March 16, 2023
Developed through a partnership between SITC and Medscape.
Additional Resources for Clinicans from SITC:
- Have increased knowledge regarding current treatment of patients with melanoma.
- Have increased knowledge regarding the mechanism of novel immunomodulators being evaluated for the treatment of melanoma.
- Demonstrate greater confidence in the ability of the interprofessional team to incorporate triplet or immunotherapy regimens.
- Have increased knowledge regarding the clinical trials evaluating novel immunotherapy approaches for the treatment of melanoma.